Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance
Kuen‐Cheh Yang, Hui‐Fang Hung, Chia‐Wen Lu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 128

Showing 51-75 of 128 citing articles:

TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease
Seon Myeong Lee, Debra Dorotea, Inji Jung, et al.
Oncotarget (2017) Vol. 8, Iss. 52, pp. 89746-89760
Open Access | Times Cited: 23
Ultrasound imaging in nonalcoholic liver disease: current applications and future developments
Kuen‐Cheh Yang, Yin‐Yin Liao, Po‐Hsiang Tsui, et al.
Quantitative Imaging in Medicine and Surgery (2019) Vol. 9, Iss. 4, pp. 546-551
Open Access | Times Cited: 22
SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway
Da Eun Kim, Bo Yoon Chang, Byeong-Min Jeon, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4534-4534
Open Access | Times Cited: 19
Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community‐based study
Tsung‐Po Chen, Michelle Lai, Wen‐Yuan Lin, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 9, pp. 1636-1643
Closed Access | Times Cited: 18
The Homocysteine and Metabolic Syndrome: A Mendelian Randomization Study
Ho‐Sun Lee, Sanghwan In, Taesung Park
Nutrients (2021) Vol. 13, Iss. 7, pp. 2440-2440
Open Access | Times Cited: 17
Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
Kaveh Naseri, Saeede Saadati, Zahra Yari, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3224-3224
Open Access | Times Cited: 11
Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis
Abdulrahman Ismaiel, Blal El Hosiny, Mohamed Ismaiel, et al.
Clinics and Research in Hepatology and Gastroenterology (2023) Vol. 47, Iss. 7, pp. 102160-102160
Closed Access | Times Cited: 6
Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects
Harry G. Preuss, Gilbert R. Kaats, Nate Mrvichin, et al.
Journal of the American College of Nutrition (2018) Vol. 37, Iss. 6, pp. 457-465
Closed Access | Times Cited: 19
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection
Thomas Krahn, Myriam Martel, Ruth Sapir‐Pichhadze, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. 5, pp. 787-797
Open Access | Times Cited: 16
Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan
Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, et al.
Journal of Gastrointestinal and Liver Diseases (2021)
Open Access | Times Cited: 15
Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
Shahinul Alam, Mohammad Eslam, SKM Nazmul Hasan, et al.
JGH Open (2021) Vol. 5, Iss. 11, pp. 1236-1249
Open Access | Times Cited: 15
Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease
Ebba Beller, Roberto Lorbeer, Daniel Keeser, et al.
European Radiology (2019) Vol. 29, Iss. 12, pp. 6662-6670
Closed Access | Times Cited: 17
Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia
И. В. Маев, А А Самсонов, Liudmila K Palgova, et al.
BMJ Open Gastroenterology (2019) Vol. 6, Iss. 1, pp. e000307-e000307
Open Access | Times Cited: 17
Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy In Vivo and In Vitro
Yanze Su, Yixing Kang, Jing Yi, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 9
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
Fabio Nascimbeni, Dante Romagnoli, Stefano Ballestri, et al.
Diseases (2018) Vol. 6, Iss. 1, pp. 17-17
Open Access | Times Cited: 15
Free-breathing 3-D quantification of infant body composition and hepatic fat using a stack-of-radial magnetic resonance imaging technique
Tess Armstrong, Karrie V. Ly, Shahnaz Ghahremani, et al.
Pediatric Radiology (2019) Vol. 49, Iss. 7, pp. 876-888
Closed Access | Times Cited: 15
Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes
Mohammad Shafi Kuchay, Narendra S. Choudhary, Sunil Kumar Mishra, et al.
JGH Open (2021) Vol. 5, Iss. 8, pp. 915-922
Open Access | Times Cited: 12
Associations of four surrogate insulin resistance indexes with non-alcoholic steatohepatitis in Chinese patients with obesity: a cross-sectional study
Jinfeng Xiao, Xinxin Zhang, Lina Chang, et al.
Endocrine (2024) Vol. 86, Iss. 2, pp. 546-555
Closed Access | Times Cited: 1
Association between hemoglobin and non-alcoholic fatty liver disease (NAFLD) in United States adults: Results from NHANES 2017–2020
Kang Yao, Zheng Chen, Wei Zhou, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102798-102798
Open Access | Times Cited: 1
Aspartate Aminotransferase to Platelet Ratio Index (APRI) as a Predictor of Metabolic Syndrome (MetS) Development in Individuals With Type 2 Diabetes Mellitus
Amir Jalisi, Rijad Jahić, Avdo Kurtović, et al.
Cureus (2024)
Open Access | Times Cited: 1
Dietary Pattern’s Role in Hepatic Epigenetic and Dietary Recommendations for the Prevention of NAFLD
Josefina Martin, David Bars‐Cortina
Nutrients (2024) Vol. 16, Iss. 17, pp. 2956-2956
Open Access | Times Cited: 1
Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome
Ji Cheol Bae, Soo Kyoung Kim, Ji Min Han, et al.
Diabetes Research and Clinical Practice (2017) Vol. 129, pp. 136-143
Closed Access | Times Cited: 13
What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Mariana Verdelho Machado, Sara Policarpo, J. Coutinho, et al.
Obesity Surgery (2019) Vol. 30, Iss. 2, pp. 560-568
Closed Access | Times Cited: 12
Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults
Inhwan Lee, Jeonghyeon Kim, Hyun‐Sik Kang
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 11, pp. 3902-3902
Open Access | Times Cited: 12
Dietary Regulation of Hepatic Triacylglycerol Content—the Role of Eucaloric Carbohydrate Restriction with Fat or Protein Replacement
Anne‐Marie Lundsgaard, Kirstine N. Bojsen‐Møller, Bente Kiens
Advances in Nutrition (2023) Vol. 14, Iss. 6, pp. 1359-1373
Open Access | Times Cited: 4

Scroll to top